These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17166684)

  • 1. Development and validation of HPLC-DAD methods for the analysis of two novel iron chelators with potent anti-cancer activity.
    Mrkvicková Z; Kovaríková P; Klimes J; Kalinowski D; Richardson DR
    J Pharm Biomed Anal; 2007 Mar; 43(4):1343-51. PubMed ID: 17166684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agents.
    Stariat J; Kovaríková P; Klimes J; Lovejoy DB; Kalinowski DS; Richardson DR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):316-22. PubMed ID: 19097949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPLC determination of a novel aroylhydrazone iron chelator (o-108) in rabbit plasma and its application to a pilot pharmacokinetic study.
    Kovaríková P; Klimes J; Sterba M; Popelová O; Gersl V; Ponka P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jul; 838(2):107-12. PubMed ID: 16725389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPLC study on stability of pyridoxal isonicotinoyl hydrazone.
    Kovaríková P; Mokrý M; Klimes J; Vávrová K
    J Pharm Biomed Anal; 2006 Jan; 40(1):105-12. PubMed ID: 16061341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatographic methods for the separation of biocompatible iron chelators from their synthetic precursors and iron chelates.
    Kovaríková P; Mokrý M; Klime J; Vávrová K
    J Sep Sci; 2004 Dec; 27(17-18):1503-10. PubMed ID: 15638159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent antitumor activity of novel iron chelators derived from di-2-pyridylketone isonicotinoyl hydrazone involves fenton-derived free radical generation.
    Chaston TB; Watts RN; Yuan J; Richardson DR
    Clin Cancer Res; 2004 Nov; 10(21):7365-74. PubMed ID: 15534113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPLC study of glimepiride under hydrolytic stress conditions.
    Kovaríková P; Klimes J; Dohnal J; Tisovská L
    J Pharm Biomed Anal; 2004 Sep; 36(1):205-9. PubMed ID: 15351067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agents.
    Becker EM; Lovejoy DB; Greer JM; Watts R; Richardson DR
    Br J Pharmacol; 2003 Mar; 138(5):819-30. PubMed ID: 12642383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the stability of aromatic hydrazones in plasma and related biological material.
    Kovaríková P; Mrkvicková Z; Klimes J
    J Pharm Biomed Anal; 2008 Jun; 47(2):360-70. PubMed ID: 18294799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validated stability indicating rapid LC method for duloxetine HCl.
    Srinivasulu P; Srinivas KS; Reddy RS; Mukkanti K; Buchireddy R
    Pharmazie; 2009 Jan; 64(1):10-3. PubMed ID: 19216224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress degradation studies on ezetimibe and development of a validated stability-indicating HPLC assay.
    Singh S; Singh B; Bahuguna R; Wadhwa L; Saxena R
    J Pharm Biomed Anal; 2006 Jun; 41(3):1037-40. PubMed ID: 16495029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPLC-DAD and MS/MS analysis of novel drug candidates from the group of aromatic hydrazones revealing the presence of geometric isomers.
    Kovaríková P; Vávrová K; Tomalová K; Schöngut M; Hrusková K; Hasková P; Klimes J
    J Pharm Biomed Anal; 2008 Sep; 48(2):295-302. PubMed ID: 18222619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms.
    Mohammadi A; Mehramizi A; Moghaddam FA; Jabarian LE; Pourfarzib M; Kashani HN
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):152-7. PubMed ID: 17466605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells.
    Noulsri E; Richardson DR; Lerdwana S; Fucharoen S; Yamagishi T; Kalinowski DS; Pattanapanyasat K
    Am J Hematol; 2009 Mar; 84(3):170-6. PubMed ID: 19140186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validated stability-indicating HPLC method for the determination of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) and its degradation products.
    Hadad GM
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):695-703. PubMed ID: 18403161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validated stability-indicating HPLC method for the determination of pridinol mesylate. Kinetics study of its degradation in acid medium.
    Bianchini RM; Castellano PM; Kaufman TS
    J Pharm Biomed Anal; 2008 Dec; 48(4):1151-60. PubMed ID: 18922659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of high-performance liquid chromatographic determination of salicylaldehyde isonicotinoyl hydrazone in rabbit plasma and application of this method to an in vivo study.
    Kovaríková P; Klimes J; Stĕrba M; Popelová O; Mokrý M; Gersl V; Ponka P
    J Sep Sci; 2005 Aug; 28(12):1300-6. PubMed ID: 16138682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugs.
    Potuckova E; Jansova H; Machacek M; Vavrova A; Haskova P; Tichotova L; Richardson V; Kalinowski DS; Richardson DR; Simunek T
    PLoS One; 2014; 9(2):e88754. PubMed ID: 24586383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a HPLC method for the analysis of promethazine hydrochloride in hot-melt extruded dosage forms.
    Thumma S; Zhang SQ; Repka MA
    Pharmazie; 2008 Aug; 63(8):562-7. PubMed ID: 18771002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients.
    Shah RB; Bryant A; Collier J; Habib MJ; Khan MA
    Int J Pharm; 2008 Aug; 360(1-2):77-82. PubMed ID: 18524511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.